Evaluation of and implications for a novel hepatitis C e-consult direct-to-treatment pilot program

Neaka Z Mohtashemi; Crystal Y Teng; Jihane Benhammou; Tien Dong; Matthew Bidwell Goetz; Arpan Patel; Jenna Kawamoto; Debika Bhattacharya

doi:10.1038/s41598-023-43052-7

Evaluation of and implications for a novel hepatitis C e-consult direct-to-treatment pilot program

Sci Rep. 2023 Oct 11;13(1):17241. doi: 10.1038/s41598-023-43052-7.

Authors

Neaka Z Mohtashemi^#^{1

2}, Crystal Y Teng^#³, Jihane Benhammou^{3

4}, Tien Dong^{3

4}, Matthew Bidwell Goetz^{3

4}, Arpan Patel^{3

4}, Jenna Kawamoto³, Debika Bhattacharya^{3

4}

Affiliations

¹ Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA. nmohtashemi@mednet.ucla.edu.
² David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. nmohtashemi@mednet.ucla.edu.
³ Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
⁴ David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.

^# Contributed equally.

Abstract

A Hepatitis C (HCV) e-Consult Direct-To-Treatment (DTT) program managed by midlevel providers was developed at the Veteran Affairs Greater Los Angeles Healthcare System (VAGLAHS) which provided remote referral and, in some, remote management of HCV. DTT patients were more likely to be initiated on HCV treatment compared to standard of care (SOC), lending support for similar programs of remote engagement in HCV care.

MeSH terms

Antiviral Agents / therapeutic use
Hepacivirus
Hepatitis C* / drug therapy
Hepatitis C, Chronic* / drug therapy
Humans
Pilot Projects
Program Evaluation
Referral and Consultation

Substances

Antiviral Agents